Financial statements Tarchomińskie Zakłady Farmaceutyczne Polfa
Balance sheet data of TARCHOMIŃSKIE ZAKŁADY FARMACEUTYCZNE POLFA
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 383 014 875,71 | 580 343 794,96 | 702 121 029,22 | 678 553,00 | 734 272,00 | 978 325,00 |
A. Fixed assets | 242 381 374,61 | 239 888 884,77 | 277 449 811,69 | 358 297,00 | 449 539,00 | 701 110,00 |
B. Current assets | 140 633 501,10 | 340 454 910,19 | 424 671 217,53 | 320 256,00 | 284 733,00 | 277 215,00 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | - | - | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | - | - | 0,00 | 0,00 |
Total liabilities | 383 014 875,71 | 580 343 794,96 | 702 121 029,22 | 678 553,00 | 734 272,00 | 978 325,00 |
A. Equity | 238 097 913,11 | 264 380 783,57 | 583 519 384,08 | 594 574,00 | 613 213,00 | 722 123,00 |
B. Liabilities and provisions for liabilities | 144 916 962,60 | 315 963 011,39 | 118 601 645,14 | 83 979,00 | 121 059,00 | 256 202,00 |
I. Long-term liabilities | 33 895 020,42 | 26 876 524,38 | 13 565 405,31 | 10 195,00 | 16 651,00 | 136 641,00 |
II. Short-term liabilities | 99 480 557,02 | 276 466 685,73 | 88 179 347,71 | 60 774,00 | 88 848,00 | 97 591,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.